Dose escalation pharmacokinetics and lipid lowering activity of a novel farnesoid X receptor modulator: 16-Dehydropregnenolone.
about
Synthesis and biological evaluations of chalcones, flavones and chromenes as farnesoid x receptor (FXR) antagonists.Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application.Role of enterohepatic recirculation in drug disposition: cooperation and complications.Pharmacokinetics of 16-dehydropregnenolone hydroxypropyl-β-cyclodextrin inclusion complex following peroral administration.Pharmacokinetics and tissue distribution study of 16-dehydropregnenolone liposome in female mice after intravenous administration.
P2860
Dose escalation pharmacokinetics and lipid lowering activity of a novel farnesoid X receptor modulator: 16-Dehydropregnenolone.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dose escalation pharmacokineti ...... lator: 16-Dehydropregnenolone.
@ast
Dose escalation pharmacokineti ...... lator: 16-Dehydropregnenolone.
@en
type
label
Dose escalation pharmacokineti ...... lator: 16-Dehydropregnenolone.
@ast
Dose escalation pharmacokineti ...... lator: 16-Dehydropregnenolone.
@en
prefLabel
Dose escalation pharmacokineti ...... lator: 16-Dehydropregnenolone.
@ast
Dose escalation pharmacokineti ...... lator: 16-Dehydropregnenolone.
@en
P2093
P2860
P356
P1476
Dose escalation pharmacokineti ...... lator: 16-Dehydropregnenolone.
@en
P2093
Ashok K Khanna
Devendra Kumar
Jitendra K Sexana
Rabi S Bhatta
Ram Pratap
P2860
P356
10.4103/0253-7613.91868
P407
P577
2012-01-01T00:00:00Z